Patents by Inventor John Birch

John Birch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160271000
    Abstract: A hand rehabilitation device includes a hand support assembly and a drive mechanism. The hand support assembly being movable to flex and extend the metacarpophalangeal and proximal interphalangeal joints of a user's hand independently.
    Type: Application
    Filed: October 22, 2015
    Publication date: September 22, 2016
    Inventors: Edward Jung Wood Park, Benjamin John Birch, Clifford Edmund Haslam, Nikolai Dechev, Imtehaze Heerah
  • Publication number: 20160167933
    Abstract: A collapsible hoist apparatus includes a lower boom assembly, a middle boom assembly, and an upper boom assembly, the boom assemblies consisting of two parallel boom arms and a transversal crossbeam, and are connected to one another by a pivotal annular support. The annular support allows the complete boom assembly to be placed in a first extended position, such that the boom assemblies extend outwardly, aligned in a pleated configuration; a fully extended position, such that the boom assemblies extend outwardly, aligned in a planar configuration; or a closed storage position, such that the boom assemblies extend inwardly, aligned in a pleated configuration.
    Type: Application
    Filed: December 15, 2014
    Publication date: June 16, 2016
    Applicant: HOIST AROUND LLC
    Inventors: Kevin John BIRCH, Raymond Scott BIRCH, Steven Adam BERRY, Raymond Francis BIRCH
  • Publication number: 20150151737
    Abstract: The present invention relates to a powertrain control system (1) for a vehicle. The powertrain control system (1) includes a torque limit calculator (47) for generating a torque control signal based (57) on one or more vehicle operating parameters. A torque request module (43) is provided for generating a torque request signal (45) and a torque control module (7) controls the torque applied by the powertrain. The torque control module (7) is configured to receive the torque request signal (45) from the torque request module (43) and the torque control signal (57) from the torque limit calculator (47) and to control the torque applied by the powertrain in dependence on the torque request signal (45) and the torque control signal (57). The present invention also relates to a control system; and a method of operating a powertrain control system.
    Type: Application
    Filed: June 7, 2013
    Publication date: June 4, 2015
    Inventors: John Birch, Paul Darnell, William Rudman
  • Publication number: 20140330466
    Abstract: A hybrid electric vehicle (HEV) comprises an engine (121) and at least one electric machine (123). The vehicle is operable in an electric vehicle (EV) mode in which the electric machine (123) develops torque to drive the vehicle whilst the engine (121) is switched off. According to the invention, the vehicle is operable when in EV mode automatically to cause engine turnover without starting the engine when a prescribed one or more conditions are met. This can be done for diagnosis or to meet braking requirements.
    Type: Application
    Filed: November 22, 2012
    Publication date: November 6, 2014
    Applicant: JAQUAR LAND ROVER LIMITED
    Inventors: Baptiste Bureau, John Birch, Adam Brant
  • Publication number: 20120197154
    Abstract: Devices and methods for sensitivity testing are provided. Disclosed devices include a flexible catheter body having a distal end and a proximal end, a peltier element, a contact element located at or near the distal end of the catheter body that can be heated or cooled by applying a voltage to the peltier element, and a contact sensor for detecting contact between a contact surface of said contact element and tissue to be tested.
    Type: Application
    Filed: January 25, 2012
    Publication date: August 2, 2012
    Inventors: Jonathan William Reeves, Malcolm John Birch
  • Publication number: 20120190069
    Abstract: A glutamine-auxotrophic human cell transfected with an exogenous DNA sequence encoding a protein or an exogenous DNA sequence capable of altering the expression of an endogenous gene encoding a protein and an exogenous DNA sequence encoding a glutamine synthetase, wherein these exogenous DNA sequences are located on one or more than one DNA construct, said transfected cell capable of producing said protein and capable of growing in a glutamine-free medium.
    Type: Application
    Filed: February 28, 2012
    Publication date: July 26, 2012
    Applicant: Lonza Biologics plc.
    Inventors: John BIRCH, Robert Charles BORASTON, Martyn SHAW
  • Publication number: 20110105551
    Abstract: An analgesic and a delivery agent are combined in a pharmaceutical composition such that, on introduction into the nasal cavity of a patient to be treated, the analgesic may be delivered to the bloodstream to produce within 30 minutes a therapeutic plasma concentration, Cther, of 0.2 ng/ml or greater which is maintained for a duration Tmaint of at least 2 hours. The analgesic may be an opioid analgesic or a non-steroidal anti-inflammatory drug.
    Type: Application
    Filed: January 12, 2011
    Publication date: May 5, 2011
    Applicants: Vernalis (R&D) Limited, Archimedes Development Corporation
    Inventors: Phillip John Birch, Ann Gail Hayes, Peter James Watts, Jonathan David Castile
  • Patent number: 7666876
    Abstract: Aqueous formulations suitable for intranasal administration comprise buprenorphine or a physiologically acceptable salt or ester thereof and (a) a pectin having a degree of esterification of less than 50%, (b) chitosan and a polyoxyethylene-polyoxypropylene copolymer (poloxamer) or (c) chitosan and hydroxypropylmethylcellulose. Such formulations can induce rapid and prolonged analgesia when delivered intranasally to a patient. The buprenorphine or buprenorphine salt or ester may be delivered to the bloodstream to produce within 30 minutes a therapeutic plasma concentration of buprenorphine, Cther, of 0.2 ng/ml or greater which is maintained for a duration Tmaint of at least 2 hours.
    Type: Grant
    Filed: March 19, 2002
    Date of Patent: February 23, 2010
    Assignees: Vernalis (R&D) Limited, Archimedes Development Limited
    Inventors: Phillip John Birch, Ann Gail Hayes, Peter James Watts, Jonathan David Castile
  • Publication number: 20100042023
    Abstract: A hand rehabilitation device includes a hand support assembly and a drive mechanism. The hand support assembly being movable to flex and extend the metacarpophalangeal and proximal interphalangeal joints of a user's hand independently.
    Type: Application
    Filed: August 11, 2009
    Publication date: February 18, 2010
    Applicant: SIMON FRASER UNIVERSITY
    Inventors: Edward Jung Wook PARK, Benjamin John BIRCH, Clifford Edmund HASLAM, Nikolai DECHEV, Imtehaze HEERAH
  • Patent number: 7439037
    Abstract: Use of aminoglycoside resistance gene product for achieving high-density growth of animal cells.
    Type: Grant
    Filed: September 26, 2002
    Date of Patent: October 21, 2008
    Assignees: Lonza Biologics PLC
    Inventors: Mohamed Al-Rubeai, Angelo Perani, Andy Racher, John Birch
  • Publication number: 20050112722
    Abstract: Use of aminoglycoside resistance gene product for achieving high-density growth of animal cells.
    Type: Application
    Filed: September 26, 2002
    Publication date: May 26, 2005
    Inventors: Mohamed Al-Rubeai, Angelo Perani, Andy Racher, John Birch
  • Publication number: 20050084928
    Abstract: A glutamine-auxotrophic human cell transfected with an exogenous DNA sequence encoding a protein or an exogenous DNA sequence capable of altering the expression of an endogenous gene encoding a protein and an exogenous DNA sequence encoding a glutamine synthetase, wherein these exogenous DNA sequences are located on one or more than one DNA construct, said transfected cell capable of producing said protein and capable of growing in a glutamine-free medium.
    Type: Application
    Filed: January 17, 2003
    Publication date: April 21, 2005
    Inventors: John Birch, Robert Boraston, Martyn Shaw
  • Publication number: 20050063182
    Abstract: A light emitting diode traffic signal apparatus and method used for shaping and directing a desired beam path of light. The apparatus orients a plurality of LED lamps using a mounting surface assembly coupled to a traffic signal head. The method includes orienting the plurality of LED lamps by mounting LED lamps to a surface assembly within the traffic signal head. The surface assembly is oriented using predetermined calculations.
    Type: Application
    Filed: September 23, 2003
    Publication date: March 24, 2005
    Inventors: John Birch, David Miller
  • Publication number: 20030013141
    Abstract: Described is a novel process for the identification of IgG-producing cells from non-IgG-producing cells by discriminating fluorescently labelled encapsulated IgG-producing and non-IgG-producing cells using flow cytometry.
    Type: Application
    Filed: August 2, 2002
    Publication date: January 16, 2003
    Inventors: John Birch, Hilary Metcalfe, Adrian Knight, Alison Vernon
  • Patent number: 5774104
    Abstract: In an active back-plane coordinate addressed liquid crystal cell whose pixels are set into one state by the application of a unidirectional potential across the thickness of the liquid crystal layer, and into the opposite state if the direction of the applied potential is reversed, refreshing is carried out in two sequential stages in order to avoid cumulative charge imbalance effects. In one stage the pixels are set to their required states, whereas in the other stage they are set to the inverse of those states.
    Type: Grant
    Filed: October 30, 1996
    Date of Patent: June 30, 1998
    Assignee: Northern Telecom Limited
    Inventors: William Alden Crossland, Martin John Birch
  • Patent number: 5751266
    Abstract: A co-ordinate addressed bistable liquid crystal cell is switchable between its two stable states by oppositely directed electric potential differences applied across the liquid crystal layer thickness between a front-plane electrode and the members of a co-ordinate address array of electrode pads of an active back-plane. Refresh data is compared with currently displayed data so that only those pixels scheduled for switching are subjected to switching stimuli. The electrode pad of a pixel scheduled for switching is taken from the potential of the front-plane electrode to a different potential by connection to a voltage source. It is then electrically isolated from that voltage source for a further period before its potential is restored to that of the front-plane electrode. This enables rows of pixels to be addressed with a line address time considerably shorter than the time necessary to effect full switching.
    Type: Grant
    Filed: February 24, 1993
    Date of Patent: May 12, 1998
    Assignee: Northern Telecom Limited
    Inventors: William Alden Crossland, Martin John Birch
  • Patent number: 5693654
    Abstract: This invention relates to a new medical use for compounds having selective agonist activity at 5-HT.sub.1 -like receptors and to pharmaceutical compositions containing them. In particular it relates to a new medical use of 3-?2-(dimethylamino)ethyl!-N-methyl-1H-indole-5-methanesulphonamide and physiologically acceptable salts and solvates thereof for the treatment or prevention of elevated intraocular pressure, in particular glaucoma.
    Type: Grant
    Filed: February 6, 1995
    Date of Patent: December 2, 1997
    Assignee: Glaxo Group Limited
    Inventor: Phillip John Birch
  • Patent number: 5311679
    Abstract: A shoe pocket for storing articles such as keys, change, etc. when engaging in athletic activities. The shoe-pocket has a pocket section with an open end formed with front and back sides. A flexible loop is attached to the back side for passing between a shoe and its laces and close the open end of the pocket. There is also a removable fastening material secured to the back side which removably fastens to the laces to prevent movement of the shoe pocket when jogging and engaging in other activities.
    Type: Grant
    Filed: November 24, 1992
    Date of Patent: May 17, 1994
    Inventor: John A. Birch, Sr.
  • Patent number: D653059
    Type: Grant
    Filed: March 30, 2011
    Date of Patent: January 31, 2012
    Inventor: John Birch